Profit Editor Khurram Husain talks about the recent strengthening of the rupee against the dollar. And also, that we’re not quite out of the woods yet.
Must Read
AstraZeneca to buy EsoBiotec for up to $1 billion
Drugmaker AstraZeneca said on Monday it will buy biotechnology firm EsoBiotec for up to $1 billion.
EsoBiotec’s Engineered NanoBody Lentiviral (ENaBL) platform can genetically modify...